Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-010954

Chief Legal Officer sold 8,275 shares at $3.00 ($24,825)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew Chief Legal Officer 2023-02-16 Sale −8,275 $3.00 $24,825 265,223 D
Open-market sales · 8,275 sh · avg $3.00 · $24,825
Loading xslF345X03/doc4.xml…